In the recent federal budget, the Australian Government revealed it would provide indemnity against liability for both the AstraZeneca Oxford and the University of Queensland COVID-19 vaccine candidates. Should either vaccine be approved, and if rare side-effects occur, the government will be responsible for providing compensation. Vaccine compensation schemes currently exist in many countries however, at present Australia is not one of them.
The following article, published in The Conversation, outlines what is known about the proposed indemnity deal and what it means for Australians.
To read the article in full follow the link below: